Tag: bristol
-
Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development
Oct 23 : Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer’s disease and other neurological disorders.Pathos AI also raised $237 million in a Series E funding round led by Bristol Myer
-
Elevator giant Otis wants to be a defensive play in an volatile market. It has to prove itself first
Otis positions itself as a long-term growth stock, but shares are down due to setbacks in its elevator service business and investors chasing the AI trade.
-
Bristol Myers buys Nvidia’s latest AI computing system for drug research
NEW YORK, July 20 : Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia to support its use of artificial intelligence across its drug discovery and development operations.The drugmaker said it will be the first life sciences company to buy an Nvidia
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Business Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news cent china cup Donald J. Trump Donald Trump economy European Union fast football France germany india Investment strategy iran Iran war markets People per politics return russia S&P 500 Index said Singapore spain Sport Stock markets technology trump ukraine United States US-Israel attack on Iran 2026 video War in Ukraine World World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
